Dont expect immediate results and a changed mindset
It will not produce weight-loss data
Obesity is directly related to the development of cardiometabolic disease (arterial hypertension, coronaric syndrome or heart failure (10) and in particular abdominal obesity is the most frequent component of metabolic syndrome along with T2D, dyslipidemia and hypertension (1113)
Possible reasons include the longer treatment duration in TRIUMPH-4 (68 vs 40 weeks), differences in how symptoms were captured, and differences in patient populations
It was shown that 92.8% of the weight lost was fat, compared to semaglutide alone at 71.8%
states: Alabama Arkansas Louisiana Mississippi Clinician Approval Since Hers offers name-brand weight loss medications, prospective patients will need to meet very specific BMI requirements that have to adhere to FDA guidelines